Valeo Financial Advisors, LLC Amarin Corp Plcuk Transaction History

Valeo Financial Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$4.26 - $6.5 $1,418 - $2,164	-333 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$4.04 - $5.31 $40 - $53	-10 Reduced 2.92%	333 $2,000
Q3 2020 Oct 28, 2020	SELL	$3.64 - $7.76 $7,280 - $15,520	-2,000 Reduced 85.36%	343 $1,000
Q3 2019 Oct 15, 2019	BUY	$13.89 - $23.16 $32,405 - $54,032	2,333 Added 23330.0%	2,343 $36,000
Q2 2019 Jul 10, 2019	SELL	$16.27 - $20.51 $8,135 - $10,255	-500 Reduced 98.04%	10 $0
Q1 2019 Apr 12, 2019	BUY	$12.61 - $22.33 $6,305 - $11,165	500 Added 5000.0%	510 $11,000
Q3 2018 Nov 01, 2018	BUY	$2.45 - $16.27 $24 - $162	10 New	10 $0

175

71M

183K

66.7K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $4.17B
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.